Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 45 entries
Sorted by: Best Match Show Resources per page
Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience.

Neuro-oncology practice

Clark GM, McDonald AM, Nabors LB, Fathalla-Shaykh H, Han X, Willey CD, Markert JM, Guthrie BL, Bredel M, Fiveash JB.
PMID: 26034629
Neurooncol Pract. 2014 Dec;1(4):172-177. doi: 10.1093/nop/npu028.

BACKGROUND: Nearly all patients with malignant glioma will have disease recurrence. Our purpose was to define the treatment toxicity and efficacy of concurrent bevazicumab (BVZ) with hypofractionated stereotactic radiosurgery (SRS) of relatively larger targets for patients with recurrent MG.METHODS:...

Cite
Clark GM, McDonald AM, Nabors LB, et al. Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience. Neurooncol Pract. 2014;1(4):172-177doi: 10.1093/nop/npu028.
Clark, G. M., McDonald, A. M., Nabors, L. B., Fathalla-Shaykh, H., Han, X., Willey, C. D., Markert, J. M., Guthrie, B. L., Bredel, M., & Fiveash, J. B. (2014). Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience. Neuro-oncology practice, 1(4), 172-177. https://doi.org/10.1093/nop/npu028
Clark, Grant M, et al. "Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience." Neuro-oncology practice vol. 1,4 (2014): 172-177. doi: https://doi.org/10.1093/nop/npu028
Clark GM, McDonald AM, Nabors LB, Fathalla-Shaykh H, Han X, Willey CD, Markert JM, Guthrie BL, Bredel M, Fiveash JB. Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience. Neurooncol Pract. 2014 Dec;1(4):172-177. doi: 10.1093/nop/npu028. PMID: 26034629; PMCID: PMC4369713.
Copy Download .nbib Format: NLM
Triol protection with 6-benzoyl-3,4-dihydro-(2H)-pyran.

Chemical communications (Cambridge, England)

Baker CD, Fawcett J, Insley CD, Messenger DS, Newland CL, Overend HL, Patel AB, Shah M, Vara B, Virdee D, Rawlings BJ.
PMID: 15795775
Chem Commun (Camb). 2005 Apr 14;(14):1883-5. doi: 10.1039/b418035f. Epub 2005 Feb 17.

6-Benzoyl-3,4-dihydro-(2H)-pyran will protect 1,2,3-triols such as glycerol as their corresponding spiro-[5-phenyl-3,6,8-trioxabicyclo[3.2.1]octane-4,2[prime or minute]-tetrahydropyran]s and 1,2,4-triols (less efficiently) as the corresponding trioxabicyclo[3.2.2]nonanes; the hexol mannitol is converted into the corresponding bis-protected product.

Cite
Baker CD, Fawcett J, Insley CD, et al. Triol protection with 6-benzoyl-3,4-dihydro-(2H)-pyran. Chem Commun (Camb). 2005;(14):1883-5doi: 10.1039/b418035f.
Baker, C. D., Fawcett, J., Insley, C. D., Messenger, D. S., Newland, C. L., Overend, H. L., Patel, A. B., Shah, M., Vara, B., Virdee, D., & Rawlings, B. J. (2005). Triol protection with 6-benzoyl-3,4-dihydro-(2H)-pyran. Chemical communications (Cambridge, England), (14), 1883-5. https://doi.org/10.1039/b418035f
Baker, Caroline D L, et al. "Triol protection with 6-benzoyl-3,4-dihydro-(2H)-pyran." Chemical communications (Cambridge, England) vol. ,14 (2005): 1883-5. doi: https://doi.org/10.1039/b418035f
Baker CD, Fawcett J, Insley CD, Messenger DS, Newland CL, Overend HL, Patel AB, Shah M, Vara B, Virdee D, Rawlings BJ. Triol protection with 6-benzoyl-3,4-dihydro-(2H)-pyran. Chem Commun (Camb). 2005 Apr 14;(14):1883-5. doi: 10.1039/b418035f. Epub 2005 Feb 17. PMID: 15795775.
Copy Download .nbib Format: NLM
KINOMIC ALTERATIONS IN ATYPICAL MENINGIOMA.

Medical research archives

Anderson JC, Taylor RB, Fiveash JB, de Wijn R, Gillespie GY, Willey CD.
PMID: 27158663
Med Res Arch. 2015 Jul;2015(3). doi: 10.18103/mra.v0i3.104.

BACKGROUND: We sought to profile Atypical Meningioma in a high-throughput manner to better understand the altered signaling within these tumors and specifically the kinases altered in recurrent atypical meningioma. Kinomic Profiles could be used to identify prognostic biomarkers for...

Cite
Anderson JC, Taylor RB, Fiveash JB, et al. KINOMIC ALTERATIONS IN ATYPICAL MENINGIOMA. Med Res Arch. 2015;2015(3)doi: 10.18103/mra.v0i3.104.
Anderson, J. C., Taylor, R. B., Fiveash, J. B., de Wijn, R., Gillespie, G. Y., & Willey, C. D. (2015). KINOMIC ALTERATIONS IN ATYPICAL MENINGIOMA. Medical research archives, 2015(3), . https://doi.org/10.18103/mra.v0i3.104
Anderson, Joshua C, et al. "KINOMIC ALTERATIONS IN ATYPICAL MENINGIOMA." Medical research archives vol. 2015,3 (2015). doi: https://doi.org/10.18103/mra.v0i3.104
Anderson JC, Taylor RB, Fiveash JB, de Wijn R, Gillespie GY, Willey CD. KINOMIC ALTERATIONS IN ATYPICAL MENINGIOMA. Med Res Arch. 2015 Jul;2015(3). doi: 10.18103/mra.v0i3.104. PMID: 27158663; PMCID: PMC4856299.
Copy Download .nbib Format: NLM
Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy.

Kidney international reports

Yamada K, Huang ZQ, Raska M, Reily C, Anderson JC, Suzuki H, Ueda H, Moldoveanu Z, Kiryluk K, Suzuki Y, Wyatt RJ, Tomino Y, Gharavi AG, Weinmann A, Julian BA, Willey CD, Novak J.
PMID: 29270528
Kidney Int Rep. 2017 Jul 19;2(6):1194-1207. doi: 10.1016/j.ekir.2017.07.002. eCollection 2017 Nov.

INTRODUCTION: IgA nephropathy is a chronic renal disease characterized by mesangial immunodeposits that contain autoantigen, which is aberrantly glycosylated IgA1 with some hinge-region METHODS: We characterized IL-6 signaling pathways involved in the overproduction of galactose-deficient IgA1. To understand molecular...

Cite
Yamada K, Huang ZQ, Raska M, et al. Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy. Kidney Int Rep. 2017;2(6):1194-1207doi: 10.1016/j.ekir.2017.07.002.
Yamada, K., Huang, Z. Q., Raska, M., Reily, C., Anderson, J. C., Suzuki, H., Ueda, H., Moldoveanu, Z., Kiryluk, K., Suzuki, Y., Wyatt, R. J., Tomino, Y., Gharavi, A. G., Weinmann, A., Julian, B. A., Willey, C. D., & Novak, J. (2017). Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy. Kidney international reports, 2(6), 1194-1207. https://doi.org/10.1016/j.ekir.2017.07.002
Yamada, Koshi, et al. "Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy." Kidney international reports vol. 2,6 (2017): 1194-1207. doi: https://doi.org/10.1016/j.ekir.2017.07.002
Yamada K, Huang ZQ, Raska M, Reily C, Anderson JC, Suzuki H, Ueda H, Moldoveanu Z, Kiryluk K, Suzuki Y, Wyatt RJ, Tomino Y, Gharavi AG, Weinmann A, Julian BA, Willey CD, Novak J. Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy. Kidney Int Rep. 2017 Jul 19;2(6):1194-1207. doi: 10.1016/j.ekir.2017.07.002. eCollection 2017 Nov. PMID: 29270528; PMCID: PMC5733772.
Copy Download .nbib Format: NLM
Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma.

Life science alliance

Schneider MM, Emmenegger M, Xu CK, Condado Morales I, Meisl G, Turelli P, Zografou C, Zimmermann MR, Frey BM, Fiedler S, Denninger V, Jacquat RP, Madrigal L, Ilsley A, Kosmoliaptsis V, Fiegler H, Trono D, Knowles TP, Aguzzi A.
PMID: 34848436
Life Sci Alliance. 2021 Nov 30;5(2). doi: 10.26508/lsa.202101270. Print 2022 Feb.

The clinical outcome of SARS-CoV-2 infections, which can range from asymptomatic to lethal, is crucially shaped by the concentration of antiviral antibodies and by their affinity to their targets. However, the affinity of polyclonal antibody responses in plasma is...

Cite
Schneider MM, Emmenegger M, Xu CK, et al. Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma. Life Sci Alliance. 2021;5(2)doi: 10.26508/lsa.202101270.
Schneider, M. M., Emmenegger, M., Xu, C. K., Condado Morales, I., Meisl, G., Turelli, P., Zografou, C., Zimmermann, M. R., Frey, B. M., Fiedler, S., Denninger, V., Jacquat, R. P., Madrigal, L., Ilsley, A., Kosmoliaptsis, V., Fiegler, H., Trono, D., Knowles, T. P., & Aguzzi, A. (2022). Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma. Life science alliance, 5(2), . https://doi.org/10.26508/lsa.202101270
Schneider, Matthias M, et al. "Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma." Life science alliance vol. 5,2 (2022). doi: https://doi.org/10.26508/lsa.202101270
Schneider MM, Emmenegger M, Xu CK, Condado Morales I, Meisl G, Turelli P, Zografou C, Zimmermann MR, Frey BM, Fiedler S, Denninger V, Jacquat RP, Madrigal L, Ilsley A, Kosmoliaptsis V, Fiegler H, Trono D, Knowles TP, Aguzzi A. Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma. Life Sci Alliance. 2021 Nov 30;5(2). doi: 10.26508/lsa.202101270. Print 2022 Feb. PMID: 34848436.
Copy Download .nbib Format: NLM
Doxorubicin Impairs Smooth Muscle Cell Contraction: Novel Insights in Vascular Toxicity.

International journal of molecular sciences

Bosman M, Krüger DN, Favere K, Wesley CD, Neutel CHG, Van Asbroeck B, Diebels OR, Faes B, Schenk TJ, Martinet W, De Meyer GRY, Van Craenenbroeck EM, Guns PDF.
PMID: 34884612
Int J Mol Sci. 2021 Nov 26;22(23). doi: 10.3390/ijms222312812.

Clinical and animal studies have demonstrated that chemotherapeutic doxorubicin (DOX) increases arterial stiffness, a predictor of cardiovascular risk. Despite consensus about DOX-impaired endothelium-dependent vasodilation as a contributing mechanism, some studies have reported conflicting results on vascular smooth muscle cell...

Cite
Bosman M, Krüger DN, Favere K, et al. Doxorubicin Impairs Smooth Muscle Cell Contraction: Novel Insights in Vascular Toxicity. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222312812.
Bosman, M., Krüger, D. N., Favere, K., Wesley, C. D., Neutel, C. H. G., Van Asbroeck, B., Diebels, O. R., Faes, B., Schenk, T. J., Martinet, W., De Meyer, G. R. Y., Van Craenenbroeck, E. M., & Guns, P. D. F. (2021). Doxorubicin Impairs Smooth Muscle Cell Contraction: Novel Insights in Vascular Toxicity. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222312812
Bosman, Matthias, et al. "Doxorubicin Impairs Smooth Muscle Cell Contraction: Novel Insights in Vascular Toxicity." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222312812
Bosman M, Krüger DN, Favere K, Wesley CD, Neutel CHG, Van Asbroeck B, Diebels OR, Faes B, Schenk TJ, Martinet W, De Meyer GRY, Van Craenenbroeck EM, Guns PDF. Doxorubicin Impairs Smooth Muscle Cell Contraction: Novel Insights in Vascular Toxicity. Int J Mol Sci. 2021 Nov 26;22(23). doi: 10.3390/ijms222312812. PMID: 34884612.
Copy Download .nbib Format: NLM
International Analysis of Sources and Human Health Risk Associated with Trace Metal Contaminants in Residential Indoor Dust.

Environmental science & technology

Isley CF, Fry KL, Liu X, Filippelli GM, Entwistle JA, Martin AP, Kah M, Meza-Figueroa D, Shukle JT, Jabeen K, Famuyiwa AO, Wu L, Sharifi-Soltani N, Doyi INY, Argyraki A, Ho KF, Dong C, Gunkel-Grillon P, Aelion CM, Taylor MP.
PMID: 34942073
Environ Sci Technol. 2021 Dec 23; doi: 10.1021/acs.est.1c04494. Epub 2021 Dec 23.

People spend increasing amounts of time at home, yet the indoor home environment remains understudied in terms of potential exposure to toxic trace metals. We evaluated trace metal (and metalloid) concentrations (As, Cu, Cr, Mn, Ni, Pb, and Zn)...

Cite
Isley CF, Fry KL, Liu X, et al. International Analysis of Sources and Human Health Risk Associated with Trace Metal Contaminants in Residential Indoor Dust. Environ Sci Technol. 2021;doi: 10.1021/acs.est.1c04494.
Isley, C. F., Fry, K. L., Liu, X., Filippelli, G. M., Entwistle, J. A., Martin, A. P., Kah, M., Meza-Figueroa, D., Shukle, J. T., Jabeen, K., Famuyiwa, A. O., Wu, L., Sharifi-Soltani, N., Doyi, I. N. Y., Argyraki, A., Ho, K. F., Dong, C., Gunkel-Grillon, P., Aelion, C. M., & Taylor, M. P. (2021). International Analysis of Sources and Human Health Risk Associated with Trace Metal Contaminants in Residential Indoor Dust. Environmental science & technology, . https://doi.org/10.1021/acs.est.1c04494
Isley, Cynthia Faye, et al. "International Analysis of Sources and Human Health Risk Associated with Trace Metal Contaminants in Residential Indoor Dust." Environmental science & technology vol. (2021). doi: https://doi.org/10.1021/acs.est.1c04494
Isley CF, Fry KL, Liu X, Filippelli GM, Entwistle JA, Martin AP, Kah M, Meza-Figueroa D, Shukle JT, Jabeen K, Famuyiwa AO, Wu L, Sharifi-Soltani N, Doyi INY, Argyraki A, Ho KF, Dong C, Gunkel-Grillon P, Aelion CM, Taylor MP. International Analysis of Sources and Human Health Risk Associated with Trace Metal Contaminants in Residential Indoor Dust. Environ Sci Technol. 2021 Dec 23; doi: 10.1021/acs.est.1c04494. Epub 2021 Dec 23. PMID: 34942073.
Copy Download .nbib Format: NLM
The Professional Socialization of Certified Athletic Trainers in the National Collegiate Athletic Association Division I Context.

Journal of athletic training

Pitney WA, Ilsley P, Rintala J.
PMID: 12937446
J Athl Train. 2002 Mar;37(1):63-70.

OBJECTIVE: To describe the professional socialization process of certified athletic trainers (ATCs) in National Collegiate Athletic Association (NCAA) Division I to guide athletic training education and professional development. DESIGN AND SETTING: We conducted a qualitative study to explore the...

Cite
Pitney WA, Ilsley P, Rintala J. The Professional Socialization of Certified Athletic Trainers in the National Collegiate Athletic Association Division I Context. J Athl Train. 2002;37(1):63-70
Pitney, W. A., Ilsley, P., & Rintala, J. (2002). The Professional Socialization of Certified Athletic Trainers in the National Collegiate Athletic Association Division I Context. Journal of athletic training, 37(1), 63-70.
Pitney, William A, et al. "The Professional Socialization of Certified Athletic Trainers in the National Collegiate Athletic Association Division I Context." Journal of athletic training vol. 37,1 (2002): 63-70.
Pitney WA, Ilsley P, Rintala J. The Professional Socialization of Certified Athletic Trainers in the National Collegiate Athletic Association Division I Context. J Athl Train. 2002 Mar;37(1):63-70. PMID: 12937446; PMCID: PMC164310.
Copy Download .nbib Format: NLM
Focal Management of Large Brain Metastases and Risk of Leptomeningeal Disease.

Advances in radiation oncology

Marcrom SR, Foreman PM, Colvin TB, McDonald AM, Kirkland RS, Popple RA, Riley KO, Markert JM, Willey CD, Bredel M, Fiveash JB.
PMID: 32051888
Adv Radiat Oncol. 2019 Aug 05;5(1):34-42. doi: 10.1016/j.adro.2019.07.016. eCollection 2020.

PURPOSE: Surgery is often used for large or symptomatic brain metastases but is associated with risk of developing leptomeningeal dissemination. Emerging data suggest that fractionated stereotactic radiation therapy (FSRT) is an effective management strategy in large brain metastases. We...

Cite
Marcrom SR, Foreman PM, Colvin TB, et al. Focal Management of Large Brain Metastases and Risk of Leptomeningeal Disease. Adv Radiat Oncol. 2019;5(1):34-42doi: 10.1016/j.adro.2019.07.016.
Marcrom, S. R., Foreman, P. M., Colvin, T. B., McDonald, A. M., Kirkland, R. S., Popple, R. A., Riley, K. O., Markert, J. M., Willey, C. D., Bredel, M., & Fiveash, J. B. (2020). Focal Management of Large Brain Metastases and Risk of Leptomeningeal Disease. Advances in radiation oncology, 5(1), 34-42. https://doi.org/10.1016/j.adro.2019.07.016
Marcrom, Samuel R, et al. "Focal Management of Large Brain Metastases and Risk of Leptomeningeal Disease." Advances in radiation oncology vol. 5,1 (2020): 34-42. doi: https://doi.org/10.1016/j.adro.2019.07.016
Marcrom SR, Foreman PM, Colvin TB, McDonald AM, Kirkland RS, Popple RA, Riley KO, Markert JM, Willey CD, Bredel M, Fiveash JB. Focal Management of Large Brain Metastases and Risk of Leptomeningeal Disease. Adv Radiat Oncol. 2019 Aug 05;5(1):34-42. doi: 10.1016/j.adro.2019.07.016. eCollection 2020. PMID: 32051888; PMCID: PMC7004932.
Copy Download .nbib Format: NLM
Concerning Relative Value of a Physician's and a Taxi Driver's Services: Re California Industrial Accident Commission.

California and western medicine

Ilsley ML.
PMID: 18746974
Cal West Med. 1945 Feb;62(2):100.

No abstract available.

Cite
Ilsley ML. Concerning Relative Value of a Physician's and a Taxi Driver's Services: Re California Industrial Accident Commission. Cal West Med. 1945;62(2):100
Ilsley, M. L. (1945). Concerning Relative Value of a Physician's and a Taxi Driver's Services: Re California Industrial Accident Commission. California and western medicine, 62(2), 100.
Ilsley, M L. "Concerning Relative Value of a Physician's and a Taxi Driver's Services: Re California Industrial Accident Commission." California and western medicine vol. 62,2 (1945): 100.
Ilsley ML. Concerning Relative Value of a Physician's and a Taxi Driver's Services: Re California Industrial Accident Commission. Cal West Med. 1945 Feb;62(2):100. PMID: 18746974; PMCID: PMC1780877.
Copy Download .nbib Format: NLM
Prognosis of primary percutaneous coronary intervention in elderly patients with ST-elevation myocardial infarction.

Journal of the Saudi Heart Association

Alkhushail A, Kohli S, Mitchel A, Smith R, Ilsely C.
PMID: 25870501
J Saudi Heart Assoc. 2015 Apr;27(2):85-90. doi: 10.1016/j.jsha.2014.12.002. Epub 2014 Dec 18.

OBJECTIVE: To evaluate the prognosis of primary percutaneous coronary intervention (PPCI) and medical therapy (MT) in elderly patients presenting with ST-elevation myocardial infarction (STEMI).METHODS: A total of 238 STEMI patients aged above 80 and treated with PPCI (n =...

Cite
Alkhushail A, Kohli S, Mitchel A, et al. Prognosis of primary percutaneous coronary intervention in elderly patients with ST-elevation myocardial infarction. J Saudi Heart Assoc. 2014;27(2):85-90doi: 10.1016/j.jsha.2014.12.002.
Alkhushail, A., Kohli, S., Mitchel, A., Smith, R., & Ilsely, C. (2015). Prognosis of primary percutaneous coronary intervention in elderly patients with ST-elevation myocardial infarction. Journal of the Saudi Heart Association, 27(2), 85-90. https://doi.org/10.1016/j.jsha.2014.12.002
Alkhushail, Abdullah, et al. "Prognosis of primary percutaneous coronary intervention in elderly patients with ST-elevation myocardial infarction." Journal of the Saudi Heart Association vol. 27,2 (2015): 85-90. doi: https://doi.org/10.1016/j.jsha.2014.12.002
Alkhushail A, Kohli S, Mitchel A, Smith R, Ilsely C. Prognosis of primary percutaneous coronary intervention in elderly patients with ST-elevation myocardial infarction. J Saudi Heart Assoc. 2015 Apr;27(2):85-90. doi: 10.1016/j.jsha.2014.12.002. Epub 2014 Dec 18. PMID: 25870501; PMCID: PMC4392347.
Copy Download .nbib Format: NLM
Colossal Terahertz Magnetoresistance at Room Temperature in Epitaxial La.

Nano letters

Lloyd-Hughes J, Mosley CD, Jones SP, Lees MR, Chen A, Jia QX, Choi EM, MacManus-Driscoll JL.
PMID: 28287748
Nano Lett. 2017 Apr 12;17(4):2506-2511. doi: 10.1021/acs.nanolett.7b00231. Epub 2017 Mar 16.

Colossal magnetoresistance (CMR) is demonstrated at terahertz (THz) frequencies by using terahertz time-domain magnetospectroscopy to examine vertically aligned nanocomposites (VANs) and planar thin films of La

Cite
Lloyd-Hughes J, Mosley CD, Jones SP, et al. Colossal Terahertz Magnetoresistance at Room Temperature in Epitaxial La. Nano Lett. 2017;17(4):2506-2511doi: 10.1021/acs.nanolett.7b00231.
Lloyd-Hughes, J., Mosley, C. D., Jones, S. P., Lees, M. R., Chen, A., Jia, Q. X., Choi, E. M., & MacManus-Driscoll, J. L. (2017). Colossal Terahertz Magnetoresistance at Room Temperature in Epitaxial La. Nano letters, 17(4), 2506-2511. https://doi.org/10.1021/acs.nanolett.7b00231
Lloyd-Hughes, J, et al. "Colossal Terahertz Magnetoresistance at Room Temperature in Epitaxial La." Nano letters vol. 17,4 (2017): 2506-2511. doi: https://doi.org/10.1021/acs.nanolett.7b00231
Lloyd-Hughes J, Mosley CD, Jones SP, Lees MR, Chen A, Jia QX, Choi EM, MacManus-Driscoll JL. Colossal Terahertz Magnetoresistance at Room Temperature in Epitaxial La. Nano Lett. 2017 Apr 12;17(4):2506-2511. doi: 10.1021/acs.nanolett.7b00231. Epub 2017 Mar 16. PMID: 28287748.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 45 entries